Cardiovascular risk among ultra-endurance runners.


Journal

The Journal of sports medicine and physical fitness
ISSN: 1827-1928
Titre abrégé: J Sports Med Phys Fitness
Pays: Italy
ID NLM: 0376337

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 16 2 2021
medline: 27 11 2021
entrez: 15 2 2021
Statut: ppublish

Résumé

Our objective was to determine the prevalence and clinical correlates of conventional cardiovascular risk factors among ultra-endurance marathon runners. An electronic internet survey to characterize modifiable cardiovascular risk factors including diabetes, hypertension, dyslipidemia, tobacco exposure and obesity (BMI>30) among competitive ultra-endurance runners. Among 290 respondents (mean±SD, 42±11 years, 31.4% female), 106 (36.6%) had at least one established cardiovascular risk factor. Female sex, younger age and participation in competitive high school or collegiate sports were associated with freedom from cardiovascular risk factors. There were no significant associations between risk factor status and either hours per week of running training (risk factor negative: 10±7 vs. risk factor positive: 11±8 hours, P=0.42) or years of ultra-endurance competition (6±8 vs. 7±9 years, P=0.38). Runners with at least one cardiovascular risk factor were more likely to have had personal or peer concerns about excessive alcohol use. Conventional cardiovascular risk factors are common among ultra-endurance runners. Early-life participation in competitive sports, rather than adult exercise habits, is associated with freedom from the development of cardiovascular risk factors during middle age. Determining mechanistic explanations for the legacy effect of early life exercise as a means to reduce cardiovascular risk among aging athletes represents an important area of future work.

Sections du résumé

BACKGROUND BACKGROUND
Our objective was to determine the prevalence and clinical correlates of conventional cardiovascular risk factors among ultra-endurance marathon runners.
METHODS METHODS
An electronic internet survey to characterize modifiable cardiovascular risk factors including diabetes, hypertension, dyslipidemia, tobacco exposure and obesity (BMI>30) among competitive ultra-endurance runners.
RESULTS RESULTS
Among 290 respondents (mean±SD, 42±11 years, 31.4% female), 106 (36.6%) had at least one established cardiovascular risk factor. Female sex, younger age and participation in competitive high school or collegiate sports were associated with freedom from cardiovascular risk factors. There were no significant associations between risk factor status and either hours per week of running training (risk factor negative: 10±7 vs. risk factor positive: 11±8 hours, P=0.42) or years of ultra-endurance competition (6±8 vs. 7±9 years, P=0.38). Runners with at least one cardiovascular risk factor were more likely to have had personal or peer concerns about excessive alcohol use.
CONCLUSIONS CONCLUSIONS
Conventional cardiovascular risk factors are common among ultra-endurance runners. Early-life participation in competitive sports, rather than adult exercise habits, is associated with freedom from the development of cardiovascular risk factors during middle age. Determining mechanistic explanations for the legacy effect of early life exercise as a means to reduce cardiovascular risk among aging athletes represents an important area of future work.

Identifiants

pubmed: 33586930
pii: S0022-4707.21.11903-6
doi: 10.23736/S0022-4707.21.11903-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1700-1705

Auteurs

Ankit B Shah (AB)

MedStar Health, Baltimore, MD, USA - ankit.b.shah@medstar.net.

Rebecca Torguson (R)

MedStar Health, Baltimore, MD, USA.

Kezia Alexander (K)

MedStar Sports Medicine Research Center, Baltimore, MD, USA.

Umar Khan (U)

MedStar Health, Baltimore, MD, USA.

Cheng Zhang (C)

MedStar Health, Baltimore, MD, USA.

Casey Fisher (C)

MedStar Health, Baltimore, MD, USA.

Martin D Hoffman (MD)

Department of Physical Medicine and Rehabilitation, University of California Davis, Sacramento, CA, USA.

Matthew Sedgley (M)

MedStar Health, Baltimore, MD, USA.

Andrew Lincoln (A)

MedStar Sports Medicine Research Center, Baltimore, MD, USA.

Aaron L Baggish (AL)

Massachusetts General Hospital, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH